HDAC4 and ovarian cancer: This aligns with findings in ovarian cancer, where HDAC4 silencing reduced cell migration (Ahn et al., 2012), and in colorectal cancer, where NaB inhibited EMT via miR-200, increasing E-cadherin and reducing Snail and vimentin expressions (Xu et al., 2018).